Trials / Completed
CompletedNCT00573560
Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients
A Feasibility Trial to Evaluate the VPD Implant System - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- CardioKinetix, Inc · Industry
- Sex
- All
- Age
- 18 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The CardioKinetix Ventricular Partitioning Device (VPD) is intended to isolate the malfunctioning portion of the left ventricle in patients with symptoms of heart failure due to ischemic heart disease. By isolating the malfunctioning portion of the left ventricle, it is hypothesized that the left ventricle will pump more effectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VPD Implant System | Percutaneous introduction using standard catheterization techniques of the VPD Implant. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2010-01-01
- Completion
- 2014-06-01
- First posted
- 2007-12-14
- Last updated
- 2017-06-22
Locations
7 sites across 2 countries: United States, Serbia
Source: ClinicalTrials.gov record NCT00573560. Inclusion in this directory is not an endorsement.